trending Market Intelligence /marketintelligence/en/news-insights/trending/3we70XHTS3K_J6iMn7A1Ag2 content esgSubNav
In This List

CVS to redeem up to $4B notes

Blog

Using ESG Analysis to Support a Sustainable Future

Video

S&P Capital IQ Pro | Powered by Expert Insights

Blog

Q&A: Streamlining Analytics for TCFD Reporting

Blog

Evergrande and the wider impact: a sentiment analytics based perspective


CVS to redeem up to $4B notes

CVS Health Corp. on Aug. 8 launched cash tender offers to purchase up to $4 billion of its outstanding 2020 and 2021 notes.

The U.S. pharmacy chain is offering to redeem any and all of its outstanding $2 billion of its 3.125% senior notes due 2020; and up to $2 billion of its floating rate notes due 2020 for $1,005 per $1,000 principal amount of notes; and 2.800% senior notes due 2020.

The company is also offering to redeem any and all of its 4.125% senior notes due 2021; 4.125% senior notes due 2021 issued by wholly owned subsidiary Aetna Inc.; and 5.450% senior notes due 2021 issued by Aetna-owned Coventry Health Care Inc.

CVS will also purchase up to $2 billion of its 3.350% senior notes due 2021, floating rate notes due 2021 for $1,006.50 per $1,000 principal amount of notes; and 2.125% senior notes due 2021.

The offer is scheduled to expire at 5 pm ET on Aug. 14. The settlement date is on Aug. 23.

Barclays Capital Inc. and Goldman Sachs & Co. LLC are acting as dealer managers for the tender offer, while D.F. King & Co. is acting as the tender and information agent.